PolarityTE names new IRO
PolarityTE has appointed Rich Haerle as its new vice president of IR and strategy, based in New York City.
Haerle, who started his career in institutional sales at Pfizer, holds a master’s degree in public health and an MBA from UCLA. He spent 13 years at Morgan Stanley working in various roles, including private wealth management and corporate access. Most recently, he served as a director for healthcare specialty sales at Deutsche Bank.
‘We are excited to name Rich to this new role as we start to build our relationships with the institutional investment community,’ says PolarityTE chairman and CEO Denver Lough in a press release.
‘We believe this is a pivotal time to educate the investment community on the developments and early success of PolarityTE. Rich’s industry knowledge, strong relationships in the financial community and presence in New York City will give PolarityTE the exposure it needs as the company continues to roll out our platform technology.’
Salt Lake City-based PolarityTE, which took over the Nasdaq ticker COOL after its 2016 merger with and subsequent divestment of Majesco Entertainment, specializes in the development of regenerative tissue products.